Dolby Laboratories (NYSE:DLB – Get Free Report) issued its quarterly earnings results on Thursday. The electronics maker reported $0.69 earnings per share for the quarter, topping the consensus estimate of $0.67 by $0.02, FiscalAI reports. The firm had revenue of $305.00 million during the quarter, compared to the consensus estimate of $311.96 million. Dolby Laboratories had a return on equity of 11.47% and a net margin of 17.85%.The company’s revenue for the quarter was down 3.3% on a year-over-year basis. During the same period last year, the company earned $0.78 earnings per share. Dolby Laboratories updated its FY 2026 guidance to 4.250-4.400 EPS and its Q4 2026 guidance to 1.130-1.280 EPS.
Here are the key takeaways from Dolby Laboratories’ conference call:
- Q4 revenue is expected to grow 23% year over year at the midpoint, reaching $362 million–$392 million, driven by a large Meta video-distribution deal, increased Dolby Atmos adoption in autos, wearables, and favorable minimum-volume-commitment timing.
- Dolby’s Video Distribution Program gained major licensees Meta and Alibaba, bringing the pool to 45 licensors and strengthening management’s confidence in reaching its goal of generating 10% of revenue from content partners by fiscal 2028.
- Automotive adoption continues to expand, with more than 40 OEM agreements and new launches from Volkswagen, Buick, and Google’s Android Auto partners; management said auto is Dolby’s fastest-growing end market and may be reported separately once it reaches 10% of licensing revenue.
- Fiscal 2026 revenue guidance was narrowed to $1.41 billion–$1.44 billion, while non-GAAP EPS is expected at $4.25–$4.40; the company is targeting approximately 100 basis points of operating-margin improvement and authorized an additional $350 million for share repurchases.
- Management is monitoring elevated memory costs, which could pressure mobile and PC unit shipments and product launches, although the company expects growth in video distribution, automotive, and wearables to offset part of the impact.
Dolby Laboratories Price Performance
Dolby Laboratories stock traded down $0.85 during mid-day trading on Thursday, reaching $51.69. The company had a trading volume of 1,149,996 shares, compared to its average volume of 876,448. Dolby Laboratories has a 1 year low of $48.26 and a 1 year high of $75.80. The company has a market capitalization of $4.89 billion, a P/E ratio of 20.43 and a beta of 0.81. The stock’s 50-day simple moving average is $52.21 and its 200-day simple moving average is $58.58.
Insider Transactions at Dolby Laboratories
Institutional Inflows and Outflows
Several hedge funds and other institutional investors have recently made changes to their positions in DLB. Cetera Investment Advisers increased its holdings in Dolby Laboratories by 7.8% during the 4th quarter. Cetera Investment Advisers now owns 5,783 shares of the electronics maker’s stock valued at $371,000 after acquiring an additional 418 shares in the last quarter. Vise Technologies Inc. lifted its holdings in shares of Dolby Laboratories by 21.4% in the third quarter. Vise Technologies Inc. now owns 4,513 shares of the electronics maker’s stock valued at $327,000 after purchasing an additional 797 shares in the last quarter. Abel Hall LLC acquired a new position in shares of Dolby Laboratories during the 4th quarter worth approximately $309,000. Fred Alger Management LLC lifted its stake in Dolby Laboratories by 14.0% in the 4th quarter. Fred Alger Management LLC now owns 4,551 shares of the electronics maker’s stock valued at $292,000 after buying an additional 560 shares in the last quarter. Finally, Boothbay Fund Management LLC purchased a new stake in Dolby Laboratories in the 4th quarter valued at approximately $274,000. Institutional investors and hedge funds own 58.56% of the company’s stock.
Trending Headlines about Dolby Laboratories
Here are the key news stories impacting Dolby Laboratories this week:
- Positive Sentiment: Raised earnings outlook: Dolby guided fiscal 2026 adjusted EPS to $4.25-$4.40, above the $4.10 consensus. Fourth-quarter revenue guidance of $362 million-$392 million also exceeded estimates of $351.1 million, suggesting management expects stronger near-term performance. Dolby Laboratories Reports Q3 Results, Boosts Share Repurchases
- Positive Sentiment: Adjusted EPS beat expectations: Third-quarter adjusted earnings were $0.69 per share, topping the $0.67 consensus, while operating cash flow increased to $167.5 million. Dolby also announced an expansion of its share-repurchase authorization, which may support per-share value. Dolby Laboratories Reports Third Quarter 2026 Financial Results
- Neutral Sentiment: Mixed investor positioning: Institutional activity was divided, with 184 investors adding shares and 192 reducing positions during the latest quarter. Recent analyst price targets remained well above the current trading level, but the limited number of targets reduces their significance.
- Negative Sentiment: Revenue missed and declined: Third-quarter revenue was $305 million, below estimates ranging from roughly $312 million to $315 million and down 3.3% year over year. This suggests continued pressure in Dolby’s core licensing and technology businesses. Dolby Laboratories Reports Q3 Earnings
- Negative Sentiment: Profitability weakened: GAAP net income fell to $28.6 million and diluted EPS to $0.30 from the prior year, while operating profit declined to $34.3 million. In addition, reported insider transactions showed selling but no purchases over the past six months, a potential sentiment headwind.
Analyst Upgrades and Downgrades
DLB has been the topic of several analyst reports. Wall Street Zen raised shares of Dolby Laboratories from a “hold” rating to a “buy” rating in a report on Saturday, May 30th. Rosenblatt Securities reiterated a “buy” rating and set a $85.00 target price on shares of Dolby Laboratories in a research report on Thursday, June 11th. Barrington Research reissued an “outperform” rating and issued a $90.00 price target on shares of Dolby Laboratories in a report on Monday, June 15th. Finally, Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Dolby Laboratories in a report on Wednesday, June 24th. Three investment analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $90.75.
Get Our Latest Report on Dolby Laboratories
Dolby Laboratories Company Profile
Dolby Laboratories, Inc is a global leader in audio and imaging technologies, specializing in the development, licensing and deployment of solutions that enhance entertainment and communications experiences. The company’s core business revolves around creating advanced audio codecs, noise reduction systems and spatial sound technologies for a wide range of applications, including cinema, broadcast, gaming, streaming and personal devices. Dolby’s licensing model enables consumer electronics manufacturers, content creators and service providers to integrate its technologies into products such as televisions, smartphones, home theater systems and set-top boxes.
Among its flagship innovations are Dolby Atmos, an immersive audio format that delivers three-dimensional soundscapes for theaters and home systems; Dolby Digital and Dolby Digital Plus, widely adopted audio compression formats for broadcast and streaming; and Dolby Vision, a high-dynamic-range imaging technology that expands color, contrast and brightness in displays.
Featured Stories
- Five stocks we like better than Dolby Laboratories
- Microsoft Just Flipped the AI Spending Narrative Overnight
- Qualcomm’s Turnaround Is Working, So Why Is Wall Street Selling?
- Meta’s Earnings Show Why Wall Street Is Losing Patience With AI Spending
- Can Starbucks Keep This Turnaround Going? The Latest Results Say Yes
Receive News & Ratings for Dolby Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dolby Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.
